Return On Assets in % of BriaCell Therapeutics Corp. from Q3 2022 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BriaCell Therapeutics Corp. quarterly/annual Return On Assets history and change rate from Q3 2022 to Q2 2025.
  • BriaCell Therapeutics Corp. Return On Assets for the quarter ending 31 Jul 2025 was -180 %, a 303% decline year-over-year.
  • BriaCell Therapeutics Corp. annual Return On Assets for 2025 was -180 %, a 303% decline from 2024.
  • BriaCell Therapeutics Corp. annual Return On Assets for 2024 was -44.7 %, a 28.8% increase from 2023.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -180 -135 -303% 01 May 2025 31 Jul 2025
Q1 2025 -182 -145 -388% 01 Feb 2025 30 Apr 2025
Q4 2024 -146 -88.1 -153% 01 Nov 2024 31 Jan 2025
Q3 2024 -191 -143 -297% 01 Aug 2024 31 Oct 2024
Q2 2024 -44.7 +18.1 +28.8% 01 May 2024 31 Jul 2024
Q1 2024 -37.4 +13.3 +26.2% 01 Feb 2024 30 Apr 2024
Q4 2023 -57.5 +0.56 +0.97% 01 Nov 2023 31 Jan 2024
Q3 2023 -48.1 -47.2 -5041% 01 Aug 2023 31 Oct 2023
Q2 2023 -62.7 01 May 2023 31 Jul 2023
Q1 2023 -50.6 01 Feb 2023 30 Apr 2023
Q4 2022 -58 01 Nov 2022 31 Jan 2023
Q3 2022 -0.94 01 Aug 2022 31 Oct 2022

BriaCell Therapeutics Corp. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -180 -135 -303% 01 Aug 2024 31 Jul 2025
2024 -44.7 +18.1 +28.8% 01 Aug 2023 31 Jul 2024
2023 -62.7 01 Aug 2022 31 Jul 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.